Check out your Company Bowl for anonymous work chats.
Digital Diagnostics, a leading artificial intelligence diagnostic health care technology company, announced that it has successfully closed a $75 million Series B funding round. This brings the company’s total amount raised to more than $130 million. Global investment firm 01 led the round, with participation from new and existing investors, including Cedar Pine, Kinderhook Industries, 8VC, Optum Ventures, OSF Ventures, Gundersen Health System, Edward – Elmhurst Health Venture Capital, and the University of Iowa. Digital Diagnostics will use the funding to accelerate its product roadmap, expand its distribution footprint, and invest in sales and marketing. Ali Satvat, Partner and Global Head of Health Care Strategic Growth at KKR and Stephen Weiss, Managing Director of Cedar Pine, have joined the company’s board of directors.